Sequential next generation sequencing analysis in homogeneously treated low risk NPM1-mutated acute myeloid leukemia with an adverse clinical outcome.

Authors :: Rossi M
Nizzoli ME
Gallì A
Roncoroni E
Zibellini S
Merati G
Rizzo E
Rocca B
Pietra D
Picone C
Brociner M
Tobar Cabrera CP
Gelli E
Santacroce E
Arcaini L
Zappasodi P
Source :: American journal of hematology [Am J Hematol] 2022 Apr; Vol. 97 (4), pp. E135-E138. Date of Electronic Publication: 2022 Jan 24.
Publication Year :: 2022

Subjects :: Humans
Mutation
Nuclear Proteins genetics
Prognosis
High-Throughput Nucleotide Sequencing
Leukemia, Myeloid, Acute genetics
Leukemia, Myeloid, Acute therapy

Full Text Access

Tools